Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$9.60 USD
+0.14 (1.48%)
Updated May 6, 2024 04:00 PM ET
After-Market: $9.59 -0.01 (-0.10%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: AMC |
3/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Theravance Biopharma (TBPH) reported earnings of $0.03 per share, beating the Zacks Consensus Estimate of $-0.04 per share. This reflects a positive earnings surprise of 175.00%. Look out for TBPH's next earnings release on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 20.83%.
Earnings History
Price & Consensus
Zacks News for TBPH
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
TBPH: What are Zacks experts saying now?
Zacks Private Portfolio Services